Acasti Pharma Ownership 2024 | Who Owns Acasti Pharma Now?
Institutional Ownership
0.00%
Insider Ownership
38.39%
Retail Ownership
61.61%
Institutional Holders
1.00
Acasti Pharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ADVISORY SERVICES NETWORK, LLC | - | - | - | -250 | -100.00% | - | Jun 30, 2023 |
Acasti Pharma's largest institutional shareholder is ADVISORY SERVICES NETWORK, LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ADVISORY SERVICES NETWORK, LLC | - | - | - | -250 | -100.00% | - | Jun 30, 2023 |
The largest Acasti Pharma shareholder by % of total assets is ADVISORY SERVICES NETWORK, LLC. The company owns 0.00 shares of Acasti Pharma (ACST), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ADVISORY SERVICES NETWORK, LLC | - | - | - | -250 | -100.00% | - | Jun 30, 2023 |
As of Jun 30 2023, Acasti Pharma's largest institutional buyer is ADVISORY SERVICES NETWORK, LLC. The company purchased -0.25K stocks of ACST, valued at -.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ADVISORY SERVICES NETWORK, LLC | - | - | - | -250 | -100.00% | - | Jun 30, 2023 |
As of Jun 30 2023, Acasti Pharma's biggest institutional seller is ADVISORY SERVICES NETWORK, LLC. The company sold -0.25K shares of ACST, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ADVISORY SERVICES NETWORK, LLC | - | - | - | -250 | -100.00% | - | Jun 30, 2023 |
Acasti Pharma's largest sold out institutional shareholder by shares sold is ADVISORY SERVICES NETWORK, LLC, sold -0.25K shares, valued at -, as of undefined.
Acasti Pharma Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
FIDELITY CONCORD STREET TRUST | 0.00% | 146,784 | - | - | Feb 29, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 18,348 | - | - | Feb 29, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 3,058 | - | - | Feb 29, 2024 |
Series Portfolios Trust | 0.00% | 72 | - | - | Jan 31, 2024 |
Series Portfolios Trust | 0.00% | 12 | - | - | Jan 31, 2024 |
Acasti Pharma's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 146.78K shares, compromising 0.00% of its total assets.
Acasti Pharma Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Mar, 23 | 1 | - |
31 Dec, 22 | 1 | - |
30 Jun, 22 | 1 | -50.00% |
31 Mar, 22 | 2 | 100.00% |
31 Dec, 21 | 1 | -50.00% |
30 Sep, 21 | 2 | -89.47% |
30 Jun, 21 | 19 | - |
31 Mar, 21 | 19 | -20.83% |
31 Dec, 20 | 24 | 33.33% |
30 Sep, 20 | 18 | -18.18% |
30 Jun, 20 | 22 | -4.35% |
31 Mar, 20 | 23 | -28.13% |
31 Dec, 19 | 32 | 28.00% |
30 Sep, 19 | 25 | 108.33% |
30 Jun, 19 | 12 | 9.09% |
31 Mar, 19 | 11 | - |
31 Dec, 18 | 11 | 57.14% |
30 Sep, 18 | 7 | -36.36% |
30 Jun, 18 | 11 | - |
31 Mar, 18 | 11 | - |
31 Dec, 17 | 11 | 37.50% |
30 Sep, 17 | 8 | 33.33% |
30 Jun, 17 | 6 | 50.00% |
31 Mar, 17 | 4 | -42.86% |
31 Dec, 16 | 7 | - |
30 Sep, 16 | 7 | - |
30 Jun, 16 | 7 | -22.22% |
31 Mar, 16 | 9 | - |
31 Dec, 15 | 9 | - |
As of 31 Mar 23, 1 institutions are holding Acasti Pharma's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Mar, 23 | 250 | - |
31 Dec, 22 | 250 | - |
30 Jun, 22 | 5,000 | -71.43% |
31 Mar, 22 | 17,500 | 250.00% |
31 Dec, 21 | 5,000 | -71.43% |
30 Sep, 21 | 17,500 | -99.48% |
30 Jun, 21 | 3,333,981 | 49.75% |
31 Mar, 21 | 2,226,407 | -46.28% |
31 Dec, 20 | 4,144,250 | 233.08% |
30 Sep, 20 | 1,244,229 | -53.57% |
30 Jun, 20 | 2,679,662 | 66.62% |
31 Mar, 20 | 1,608,263 | -68.61% |
31 Dec, 19 | 5,124,260 | 45.25% |
30 Sep, 19 | 3,527,912 | 40.08% |
30 Jun, 19 | 2,518,543 | 4.59% |
31 Mar, 19 | 2,408,127 | -11.25% |
31 Dec, 18 | 2,713,411 | 576.02% |
30 Sep, 18 | 401,383 | -67.55% |
30 Jun, 18 | 1,237,072 | 145.63% |
31 Mar, 18 | 503,630 | -68.84% |
31 Dec, 17 | 1,616,069 | 209.11% |
30 Sep, 17 | 522,816 | -2.12% |
30 Jun, 17 | 534,125 | 8.42% |
31 Mar, 17 | 492,658 | -5.66% |
31 Dec, 16 | 522,199 | -8.34% |
30 Sep, 16 | 569,686 | 6.30% |
30 Jun, 16 | 535,947 | -6.98% |
31 Mar, 16 | 576,146 | 2.80% |
31 Dec, 15 | 560,478 | - |
Acasti Pharma (ACST) has 250.00 shares outstanding as of 31 Mar 23, up 0.00% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Mar, 23 | 0.00% | 166666.67% |
31 Dec, 22 | 0.00% | - |
30 Jun, 22 | 0.01% | 722.78% |
31 Mar, 22 | 0.04% | 30973.45% |
31 Dec, 21 | 0.01% | 396.07% |
30 Sep, 21 | 0.05% | 2.09% |
30 Jun, 21 | 1.60% | 140.15% |
31 Mar, 21 | 1.07% | 7.59% |
31 Dec, 20 | 3.75% | 219.25% |
30 Sep, 20 | 1.31% | 14.98% |
30 Jun, 20 | 2.95% | 81.72% |
31 Mar, 20 | 1.90% | 5.44% |
31 Dec, 19 | 5.91% | 32.79% |
30 Sep, 19 | 4.25% | 41.39% |
30 Jun, 19 | 3.20% | 34.15% |
31 Mar, 19 | 3.06% | 20.86% |
31 Dec, 18 | 3.83% | 319.42% |
30 Sep, 18 | 1.10% | 7.25% |
30 Jun, 18 | 3.89% | 155.25% |
31 Mar, 18 | 1.58% | 1.41% |
31 Dec, 17 | 10.61% | 84.14% |
30 Sep, 17 | 3.55% | 26.94% |
30 Jun, 17 | 3.63% | 45.74% |
31 Mar, 17 | 2.82% | 11.85% |
31 Dec, 16 | 4.87% | 17.24% |
30 Sep, 16 | 5.32% | 21.25% |
30 Jun, 16 | 5.00% | 17.29% |
31 Mar, 16 | 5.38% | 19.65% |
31 Dec, 15 | 5.23% | - |
As of 31 Mar 23, Acasti Pharma is held by 0.00% institutional shareholders, representing a 166666.67% growth compared to 31 Dec 22.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Mar, 23 | - | -100.00% |
31 Dec, 22 | 1 | - |
30 Jun, 22 | - | -100.00% |
31 Mar, 22 | 1 | - |
31 Dec, 21 | - | - |
30 Sep, 21 | - | -100.00% |
30 Jun, 21 | 9 | 12.50% |
31 Mar, 21 | 8 | -50.00% |
31 Dec, 20 | 16 | 300.00% |
30 Sep, 20 | 4 | -33.33% |
30 Jun, 20 | 6 | -50.00% |
31 Mar, 20 | 12 | -47.83% |
31 Dec, 19 | 23 | 35.29% |
30 Sep, 19 | 17 | 183.33% |
30 Jun, 19 | 6 | -14.29% |
31 Mar, 19 | 7 | -12.50% |
31 Dec, 18 | 8 | 300.00% |
30 Sep, 18 | 2 | -71.43% |
30 Jun, 18 | 7 | 75.00% |
31 Mar, 18 | 4 | -42.86% |
31 Dec, 17 | 7 | 75.00% |
30 Sep, 17 | 4 | 100.00% |
30 Jun, 17 | 2 | - |
31 Mar, 17 | - | -100.00% |
31 Dec, 16 | 2 | -50.00% |
30 Sep, 16 | 4 | 100.00% |
30 Jun, 16 | 2 | -50.00% |
31 Mar, 16 | 4 | -55.56% |
31 Dec, 15 | 9 | - |
- institutional shareholders have increased their position in ACST stock as of 31 Mar 23 compared to 1 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Mar, 23 | - | - |
31 Dec, 22 | - | - |
30 Jun, 22 | - | - |
31 Mar, 22 | - | - |
31 Dec, 21 | - | -100.00% |
30 Sep, 21 | 2 | -50.00% |
30 Jun, 21 | 4 | 300.00% |
31 Mar, 21 | 1 | - |
31 Dec, 20 | 1 | -83.33% |
30 Sep, 20 | 6 | 100.00% |
30 Jun, 20 | 3 | -40.00% |
31 Mar, 20 | 5 | 25.00% |
31 Dec, 19 | 4 | 33.33% |
30 Sep, 19 | 3 | - |
30 Jun, 19 | 3 | - |
31 Mar, 19 | - | -100.00% |
31 Dec, 18 | 1 | -50.00% |
30 Sep, 18 | 2 | - |
30 Jun, 18 | - | -100.00% |
31 Mar, 18 | 3 | 50.00% |
31 Dec, 17 | 2 | 100.00% |
30 Sep, 17 | 1 | - |
30 Jun, 17 | 1 | - |
31 Mar, 17 | 1 | -75.00% |
31 Dec, 16 | 4 | - |
30 Sep, 16 | - | -100.00% |
30 Jun, 16 | 2 | - |
31 Mar, 16 | 2 | - |
31 Dec, 15 | - | - |
- institutional shareholders have reduced their position in ACST stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar, 23 | 1 | - | 250 | - | 0.00% | 166666.67% | - | -100.00% | - | - |
31 Dec, 22 | 1 | - | 250 | - | 0.00% | - | 1 | - | - | - |
30 Jun, 22 | 1 | -50.00% | 5,000 | -71.43% | 0.01% | 722.78% | - | -100.00% | - | - |
31 Mar, 22 | 2 | 100.00% | 17,500 | 250.00% | 0.04% | 30973.45% | 1 | - | - | - |
31 Dec, 21 | 1 | -50.00% | 5,000 | -71.43% | 0.01% | 396.07% | - | - | - | -100.00% |
30 Sep, 21 | 2 | -89.47% | 17,500 | -99.48% | 0.05% | 2.09% | - | -100.00% | 2 | -50.00% |
30 Jun, 21 | 19 | - | 3,333,981 | 49.75% | 1.60% | 140.15% | 9 | 12.50% | 4 | 300.00% |
31 Mar, 21 | 19 | -20.83% | 2,226,407 | -46.28% | 1.07% | 7.59% | 8 | -50.00% | 1 | - |
31 Dec, 20 | 24 | 33.33% | 4,144,250 | 233.08% | 3.75% | 219.25% | 16 | 300.00% | 1 | -83.33% |
30 Sep, 20 | 18 | -18.18% | 1,244,229 | -53.57% | 1.31% | 14.98% | 4 | -33.33% | 6 | 100.00% |
30 Jun, 20 | 22 | -4.35% | 2,679,662 | 66.62% | 2.95% | 81.72% | 6 | -50.00% | 3 | -40.00% |
31 Mar, 20 | 23 | -28.13% | 1,608,263 | -68.61% | 1.90% | 5.44% | 12 | -47.83% | 5 | 25.00% |
31 Dec, 19 | 32 | 28.00% | 5,124,260 | 45.25% | 5.91% | 32.79% | 23 | 35.29% | 4 | 33.33% |
30 Sep, 19 | 25 | 108.33% | 3,527,912 | 40.08% | 4.25% | 41.39% | 17 | 183.33% | 3 | - |
30 Jun, 19 | 12 | 9.09% | 2,518,543 | 4.59% | 3.20% | 34.15% | 6 | -14.29% | 3 | - |
31 Mar, 19 | 11 | - | 2,408,127 | -11.25% | 3.06% | 20.86% | 7 | -12.50% | - | -100.00% |
31 Dec, 18 | 11 | 57.14% | 2,713,411 | 576.02% | 3.83% | 319.42% | 8 | 300.00% | 1 | -50.00% |
30 Sep, 18 | 7 | -36.36% | 401,383 | -67.55% | 1.10% | 7.25% | 2 | -71.43% | 2 | - |
30 Jun, 18 | 11 | - | 1,237,072 | 145.63% | 3.89% | 155.25% | 7 | 75.00% | - | -100.00% |
31 Mar, 18 | 11 | - | 503,630 | -68.84% | 1.58% | 1.41% | 4 | -42.86% | 3 | 50.00% |
31 Dec, 17 | 11 | 37.50% | 1,616,069 | 209.11% | 10.61% | 84.14% | 7 | 75.00% | 2 | 100.00% |
30 Sep, 17 | 8 | 33.33% | 522,816 | -2.12% | 3.55% | 26.94% | 4 | 100.00% | 1 | - |
30 Jun, 17 | 6 | 50.00% | 534,125 | 8.42% | 3.63% | 45.74% | 2 | - | 1 | - |
31 Mar, 17 | 4 | -42.86% | 492,658 | -5.66% | 2.82% | 11.85% | - | -100.00% | 1 | -75.00% |
31 Dec, 16 | 7 | - | 522,199 | -8.34% | 4.87% | 17.24% | 2 | -50.00% | 4 | - |
30 Sep, 16 | 7 | - | 569,686 | 6.30% | 5.32% | 21.25% | 4 | 100.00% | - | -100.00% |
30 Jun, 16 | 7 | -22.22% | 535,947 | -6.98% | 5.00% | 17.29% | 2 | -50.00% | 2 | - |
31 Mar, 16 | 9 | - | 576,146 | 2.80% | 5.38% | 19.65% | 4 | -55.56% | 2 | - |
31 Dec, 15 | 9 | - | 560,478 | - | 5.23% | - | 9 | - | - | - |
Acasti Pharma Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Acasti Pharma's stock was made by DelAversano Robert J on Jan 08 2024, selling 42,000 shares at $2.13 per share (valued at $89.25K). The last insider buy of ACST was made by Kavuru Vimal on Sep 27 2023, buying 676,371 shares at $1.85 per share (worth $1.25M).
Acasti Pharma Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | 5 | - | - |
Q1 2024 | - | 1 | - |
Q4 2023 | 5 | 2 | 250.00% |
Q3 2023 | 10 | - | - |
Q2 2023 | - | 1 | - |
Q3 2022 | 4 | 3 | 133.33% |
Q2 2022 | 4 | - | - |
Q1 2022 | - | - | - |
Q4 2021 | 9 | 2 | 450.00% |
Q3 2021 | - | 2 | - |
Q3 2020 | - | - | - |
Q2 2020 | - | 18 | - |
Q1 2017 | - | 3 | - |
5 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Acasti Pharma's insiders, as of Q2 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | - | - | - |
Q1 2024 | - | - | - |
Q4 2023 | - | - | - |
Q3 2023 | 3 | - | - |
Q2 2023 | - | - | - |
Q3 2022 | - | - | - |
Q2 2022 | - | - | - |
Q1 2022 | - | - | - |
Q4 2021 | - | - | - |
Q3 2021 | - | - | - |
Q3 2020 | - | - | - |
Q2 2020 | - | - | - |
Q1 2017 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Acasti Pharma's stocks.
Acasti Pharma Peer Ownership
Ticker | Company |
---|---|
GOVX | GeoVax Labs, Inc. |
ARDS | Aridis Pharmaceuticals, Inc. |
PULM | Pulmatrix, Inc. |
ABVC | ABVC BioPharma, Inc. |
BPTH | Bio-Path Holdings, Inc. |
ADTX | Aditxt, Inc. |
TNXP | Tonix Pharmaceuticals Holding Corp. |
DFFN | CervoMed Inc. |
AKTX | Akari Therapeutics, Plc |
JAGX | Jaguar Health, Inc. |
MBRX | Moleculin Biotech, Inc. |
ONTX | Traws Pharma, Inc. |
CBIO | Gyre Therapeutics, Inc. |
OCGN | Ocugen, Inc. |
ACST Ownership FAQ
Who Owns Acasti Pharma?
Acasti Pharma is owned by institutional shareholders (0.00%), insiders (38.39%), and public (61.61%). The largest institutional shareholder of Acasti Pharma is ADVISORY SERVICES NETWORK, LLC (0% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).
Who are the major institutional shareholders of Acasti Pharma?
Acasti Pharma's major institutional shareholders are ADVISORY SERVICES NETWORK, LLC. The top five shareholders own together 0% of the company's share outstanding.
How many Acasti Pharma shareholders are there?
As of Mar 2023, there are 1 institutional shareholders of Acasti Pharma.
What percentage of Acasti Pharma is owned by ADVISORY SERVICES NETWORK, LLC?
ADVISORY SERVICES NETWORK, LLC owns 0 shares of Acasti Pharma, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2023).